BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Women's health
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, November 16, 2024
See today's BioWorld
Home
» Enumeral joins OTCQB with $21.5M private placement
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Enumeral joins OTCQB with $21.5M private placement
Aug. 7, 2014
By
Michael Fitzhugh
No Comments
Enumeral Biomedical Holdings Inc., an early stage immunomodulator discovery and development venture, has transitioned to the OTCQB through a reverse merger with a shell company simultaneous with the close of a $21.5 million equity financing.
BioWorld